- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2023
- 148 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- July 2023
- 84 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- February 2022
- 80 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- August 2022
- 118 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2022
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 97 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- October 2019
- 102 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- August 2022
- 203 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- November 2023
- 230 Pages
Global
From €5617EUR$5,820USD£4,819GBP
- Book
- April 2019
- 392 Pages
The Stroke Management market within the context of Cardiology is focused on the diagnosis, treatment, and prevention of stroke. This includes the use of medical devices, such as stents, catheters, and imaging systems, to diagnose and treat stroke. Additionally, the market includes the development of drugs and therapies to reduce the risk of stroke and improve patient outcomes.
The market is driven by the increasing prevalence of stroke, the growing demand for minimally invasive treatments, and the development of new technologies. Additionally, the increasing focus on preventive care and the rising awareness of stroke risk factors are expected to drive the market.
Some of the major companies in the Stroke Management market include Medtronic, Abbott, Boston Scientific, Johnson & Johnson, Stryker, and Siemens Healthineers. Show Less Read more
